reports
- GlobalData Healthcare Department
Abivax SA (ABVX) - Financial Analysis Review
Abivax SA (ABVX) - Financial Analysis Review Summary Abivax SA (Abivax) is a biotechnology company that researches, develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases. Its pipeline product portfolio includes ABX464, a small molecule against HIV; ABX311 for chikungunya; ABX544 to treat EBOLA virus infection; and ABX196, an immune enhancer candidate for vaccination. GlobalData's Abivax SA (ABVX) - Financial Analysis Review provides...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.